These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 10174313)
1. Economic evaluation of the use of nadroparin calcium in the prophylaxis of deep vein thrombosis and pulmonary embolism in surgical patients in Italy. Lloyd A; Aitken JA; Hoffmeyer UK; Kelso EJ; Wakerly EC; Barber ND Pharmacoeconomics; 1997 Oct; 12(4):475-85. PubMed ID: 10174313 [TBL] [Abstract][Full Text] [Related]
3. Cost analysis of ardeparin versus enoxaparin for the prophylaxis of deep vein thrombosis after knee arthroplasty. Wade WE Clin Ther; 1998; 20(2):347-51. PubMed ID: 9589825 [TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of the use of nadroparin in the treatment of deep-vein thrombosis in Switzerland. Lloyd AC; Aitken JA; Hoffmeyer UK; Kelso EJ; Wakerly EC; Barber ND Ann Pharmacother; 1997; 31(7-8):842-6. PubMed ID: 9220041 [TBL] [Abstract][Full Text] [Related]
5. Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders. Davis R; Faulds D Drugs Aging; 1997 Apr; 10(4):299-322. PubMed ID: 9108990 [TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism. Anderson DR; O'Brien BJ Pharmacoeconomics; 1997 Jul; 12(1):17-29. PubMed ID: 10169385 [TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Nurmohamed MT; van Riel AM; Henkens CM; Koopman MM; Que GT; d'Azemar P; Büller HR; ten Cate JW; Hoek JA; van der Meer J; van der Heul C; Turpie AG; Haley S; Sicurella A; Gent M Thromb Haemost; 1996 Feb; 75(2):233-8. PubMed ID: 8815566 [TBL] [Abstract][Full Text] [Related]
8. Nadroparin calcium. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders. Barradell LB; Buckley MM Drugs; 1992 Nov; 44(5):858-88. PubMed ID: 1280570 [TBL] [Abstract][Full Text] [Related]
9. [Economic analysis of dalteparin use in knee surgery at Instituto Mexicano del Seguro Social]. Arreola-Ornelas H; Rosado-Buzzo A; García-Mollinedo L; Dorantes Aguilar J; Muciño-Ortega E; Mould-Quevedo JF Cir Cir; 2012; 80(5):411-8. PubMed ID: 23351443 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of hospital cost of six days of treatment of deep venous thrombosis. Comparison of subcutaneous nadroparin and intravenous heparin in 40 patients]. Lévesque H; Cailleux N; Vasse D; Legallicier B; Moore N; Borg JY; Hantute N; Thuillez C; Courtois H Therapie; 1994; 49(2):101-5. PubMed ID: 7817331 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of prevention of thromboembolic complications with LMW-heparin in experiment. Szücs G; Mikó I; Ajzner E; Póti L; Szepesi K; Furka I Acta Chir Hung; 1997; 36(1-4):356-8. PubMed ID: 9408400 [TBL] [Abstract][Full Text] [Related]
12. Thromboembolic prophylaxis in orthopaedic trauma patients: a comparison between a fixed dose and an individually adjusted dose of a low molecular weight heparin (nadroparin calcium). Haentjens P Injury; 1996 Jul; 27(6):385-90. PubMed ID: 8881132 [TBL] [Abstract][Full Text] [Related]
13. A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery. Oster G; Tuden RL; Colditz GA JAMA; 1987 Jan; 257(2):203-8. PubMed ID: 3098991 [TBL] [Abstract][Full Text] [Related]
14. Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group. Gazzaniga GM; Angelini G; Pastorino G; Santoro E; Lucchini M; Dal Prà ML Int Surg; 1993; 78(3):271-5. PubMed ID: 8276557 [TBL] [Abstract][Full Text] [Related]
15. Discoveries in thrombosis care for medical patients. Cohen AT Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():13-7. PubMed ID: 12232818 [TBL] [Abstract][Full Text] [Related]
16. [The use of fraxiparin in orthopedic trauma patients to prevent and treat pulmonary embolism and deep venous thrombosis of the extremities]. Mironov SP; Burmakova GM; Fedotova TM Ter Arkh; 1993; 65(10):82-3. PubMed ID: 8296243 [No Abstract] [Full Text] [Related]
17. Efficacy and safety of weight-adapted nadroparin calcium vs. heparin sodium in prevention of clinically evident thromboembolic complications in 1,190 general surgical patients. Egger B; Schmid SW; Naef M; Wildi S; Büchler MW Dig Surg; 2000; 17(6):602-609. PubMed ID: 11155006 [TBL] [Abstract][Full Text] [Related]
18. [The postoperative prevention of deep venous thrombosis and pulmonary embolism with defibrotide versus heparin-calcium: a randomized clinical multicenter study of 1296 patients undergoing major abdominal surgery]. Di Somma C; Canepa G; Gipponi M; Frascio M Ann Ital Chir; 1992; 63(1):83-8. PubMed ID: 1605451 [TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the Netherlands. Postma MJ; Kappelhoff BS; van Hulst M; Brouwers JR J Med Econ; 2012; 15(5):878-86. PubMed ID: 22563715 [TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial. Kalfarentzos F; Stavropoulou F; Yarmenitis S; Kehagias I; Karamesini M; Dimitrakopoulos A; Maniati A Obes Surg; 2001 Dec; 11(6):670-6. PubMed ID: 11775562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]